GL1X · GenesisL1 explorer

Research workbench

Inhibitors of JAK2 kinase domain

Analyse Inhibitors of JAK2 kinase domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4C61
Type
protein
Length
550 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.1.112
UniProt
O60674
Ligands
LMM
Pockets
4 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.1.112)protein27447% helix, 18% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.1.112)protein27645% helix, 18% strandO60674

Ligands and binding sites

  • LMM · N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-7-methyl-N4-(1-methylimidazol-4-yl)thieno[3,2-d]pyrimidine-2,4-diamine · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19070.720.7761empty
23890.650.7949LMM
32940.590.7841LMM
4500.280.7417empty

Interfaces

1 interface between chains.

  • A–B · 328 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 4C61 · Inhibitors of Jak2 Kinase domain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.